header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

Knee

MEDIAL PATTELOFEMORAL LIGAMENT RECONSTRUCTION WITH SEMITENDINOSIS AUTOGRAFT MINIMUM 2 YEAR (MIDTERM) FUNCTIONAL RESULTS

British Association for Surgery of the Knee (BASK)



Abstract

Purpose

To assess the midterm functional results after Medial Patellofemoral Ligament (MPFL) reconstruction with single semitendinosis autograft in patients with patellofemoral instability.

Methods - Results

Forty six knees (45 patients) with patellofemoral instability were treated with surgical stabilisation of the patella with a single semitendinosis autograft and followed up for a minimum of 24 months. The average follow-up was 33.5 months (range 24-54 months). Clinical evidence of patellar instability and radiological (MRI) evidence of MPFL rupture or deficiency was documented prior to surgery. The average post injury interval was 22.3 months. Ipsilateral joint co-morbidities included previous lateral release or distal realignment (n=10), patellofemoral joint (PFJ) dysplasia (n=14) and concurrent ACL, PCL and/or MCL rupture (n=6). Knee function was assessed preoperatively and postoperatively with the use of Kujala, Tegner, Lysholm and International Knee Documentation Committee (IKDC) scores. There were 34 male and 11 female patients with a mean age of 32.5 years (range 17 - 60 years). All measured knee function scores improved postoperatively. Kujala score improved from 58 to 77 (95%CI +/− 9.71). Tegner score improved from 3 to 5 (95%CI+/− 0.65). IKDC score improved from 51 to 75 (95%CI +/− 5.27) and Lysholm score improved from 59 to 79 (95%CI +/− 6.5).

Conclusions

MPFL reconstruction with semitendinosis autograft is an effective treatment at a minimum of 24 months (midterm) follow-up in patients with patellofemoral instability even in the presence of heterogeneous knee co-morbidities such as PFJ dysplasia, previous lateral release and failed realignment surgery.